Atrial Flutter Ablation in the iCMR — VISABL-AFL

Atrial Flutter Typical Clinical Trial

Official title:
Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter

Status Not yet recruiting

Clinical Trial Summary

The VISABL-AFL clinical investigation is a prospective, single-arm, multi-center, interventional, Investigational Device Exemption (IDE) trial. The primary objectives of VISABL-AFL are to assess the safety and efficacy of radiofrequency (RF) ablation of type-I atrial flutter performed with the Vision-MR Ablation Catheter 2.0 in the iCMR environment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05904548
Study type	Interventional
Source	Imricor Medical Systems
Contact	Kate Lindborg, PhD
Phone	9528188400
Email	kate.lindborg@imricor.com
Status	Not yet recruiting
Phase	N/A
Start date	September 15, 2023
Completion date	December 15, 2023

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT06056557` - Versatility of a Circular Multielectrode Catheter in the Individualized Recognition & Treatment of Atrial Fibrillation and Related Arrhythmias Using Pulsed Field Energy	N/A
Recruiting	`NCT04678258` - Zero Fluoroscopy Voltage Guided vs. Linear CTI Ablation	N/A
Not yet recruiting	`NCT06406686` - Ablation Index in Standard vs. High Power Radiofrequency Ablation for Typical Atrial Flutter: A Randomized Study (AITAF)	N/A
Recruiting	`NCT04900831` - Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping
Completed	`NCT03401099` - Cryoballoon Ablation as First Line Treatment of Atrial Flutter	N/A